ETF profile for Bushido Capital US Equity ETF (SMRI) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
SMRI ETF Profile
| Family: |
Bushido Capital |
| Name: |
Bushido Capital US Equity ETF |
|
|
| Inception Date: |
14-Sep-2023 |
| Termination Date: |
|
| Investment Objective: |
The Bushido Capital US Equity Fund utilizes a systematic, fundamental value approach to individual stock selection that incorporates both quantitative and qualitative analysis. The Fund seeks to identify and invest in companies with the following characteristics: high free cash flow generation relative to the capital employed in the business, strong returns on capital over full economic cycles, management teams with track records of shareholder friendly capital allocation decisions, and current market prices trading for less than the portfolio manager's estimate of the companies intrinsic value per share. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| Accenture PLC |
ACN |
2.7900% |
| Intuit Inc |
INTU |
2.3900% |
| United Therapeutics Corp |
UTHR |
2.3600% |
| Autodesk Inc |
ADSK |
2.3400% |
| Eli Lilly & Co |
LLY |
2.3100% |
| Zoetis Inc |
ZTS |
2.2600% |
| Leidos Holdings Inc |
LDOS |
2.2500% |
| ConocoPhillips |
COP |
2.2300% |
| Cardinal Health Inc |
CAH |
2.2100% |
| Royalty Pharma PLC |
RPRX |
2.2000% |
|
Top 10 Holdings Weight: |
23.3% |
| Number of Holdings: |
51 |
| Shares Outstanding: |
15,005,000 |
| Total Net Assets: |
707,185,664 |
| NAV: |
47.11 |
| Net Expense Ratio: |
0.71% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
US |
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
|
| Industry: |
|
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Domestic |
